Legis Daily

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

USA117th CongressHRES-1274| House 
| Updated: 9/29/2022
Robert E. Latta

Robert E. Latta

Republican Representative

Ohio

Cosponsors (1)
Neal P. Dunn (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This resolution directs the President to provide, within 14 days, certain information and documents concerning communications between the Department of Health and Human Services, the White House, the Department of Justice, and other agencies about recommendations for reducing the supply of illicitly manufactured fentanyl-related substances.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 26, 2022
Introduced in House
Jul 26, 2022
Referred to the House Committee on Energy and Commerce.
Jul 27, 2022
Referred to the Subcommittee on Health.
Sep 21, 2022
Committee Consideration and Mark-up Session Held.
Sep 21, 2022
Subcommittee on Health Discharged.
Sep 21, 2022
Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.
Sep 29, 2022
Placed on the House Calendar, Calendar No. 133.
Sep 29, 2022
Reported by the Committee on Energy and Commerce. H. Rept. 117-527.
  • July 26, 2022
    Introduced in House


  • July 26, 2022
    Referred to the House Committee on Energy and Commerce.


  • July 27, 2022
    Referred to the Subcommittee on Health.


  • September 21, 2022
    Committee Consideration and Mark-up Session Held.


  • September 21, 2022
    Subcommittee on Health Discharged.


  • September 21, 2022
    Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.


  • September 29, 2022
    Placed on the House Calendar, Calendar No. 133.


  • September 29, 2022
    Reported by the Committee on Energy and Commerce. H. Rept. 117-527.

Health

Congressional-executive branch relationsDrug trafficking and controlled substancesExecutive Office of the PresidentGovernment information and archives

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

USA117th CongressHRES-1274| House 
| Updated: 9/29/2022
This resolution directs the President to provide, within 14 days, certain information and documents concerning communications between the Department of Health and Human Services, the White House, the Department of Justice, and other agencies about recommendations for reducing the supply of illicitly manufactured fentanyl-related substances.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 26, 2022
Introduced in House
Jul 26, 2022
Referred to the House Committee on Energy and Commerce.
Jul 27, 2022
Referred to the Subcommittee on Health.
Sep 21, 2022
Committee Consideration and Mark-up Session Held.
Sep 21, 2022
Subcommittee on Health Discharged.
Sep 21, 2022
Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.
Sep 29, 2022
Placed on the House Calendar, Calendar No. 133.
Sep 29, 2022
Reported by the Committee on Energy and Commerce. H. Rept. 117-527.
  • July 26, 2022
    Introduced in House


  • July 26, 2022
    Referred to the House Committee on Energy and Commerce.


  • July 27, 2022
    Referred to the Subcommittee on Health.


  • September 21, 2022
    Committee Consideration and Mark-up Session Held.


  • September 21, 2022
    Subcommittee on Health Discharged.


  • September 21, 2022
    Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.


  • September 29, 2022
    Placed on the House Calendar, Calendar No. 133.


  • September 29, 2022
    Reported by the Committee on Energy and Commerce. H. Rept. 117-527.
Robert E. Latta

Robert E. Latta

Republican Representative

Ohio

Cosponsors (1)
Neal P. Dunn (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional-executive branch relationsDrug trafficking and controlled substancesExecutive Office of the PresidentGovernment information and archives